Skip to content
Open access

Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis

Oct 2026 · Liver international (Print) · Vol 46 · 0 citations · 49 references
Medicine

TL;DR

This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with biomarkers of gut permeability and systemic inflammation.

Abstract

YAQ001 is a novel, non‐absorbable, gut‐restricted, multiporous, carbon bead adsorbent. Pre‐clinical studies and a clinical trial suggested its therapeutic potential and safety in patients with cirrhosis. This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with biomarkers of gut permeability and systemic inflammation.

Read PDF

Similar papers

Oct 2026

Integrated Analysis of Gut Microbiota and Fecal Metabolites in Chinese Patients With Rheumatoid Arthritis: Associations With Disease Activity

This study aimed to delineate fecal microbiome and metabolomic signatures in RA and identify biomarkers associated with disease activity and identify biomarkers associated with disease activity.

Jing Liang, Xiang-Yu Wei, Chen Shang et al. · 0 citations
Open access Oct 2026

Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes

ABSTRACT In a recent paper published in Cancer Cell, we identified subclinical cholestasis as an accessible imprint of gut dysbiosis predicting resistance to immune checkpoint blockade. Our work connects γ-glutamyl transferase, bile-acid remodeling, and MAdCAM-1 loss to compromised antitumor immunity, opening avenues f...

Anne-Laure Mallard de La Varende, M. Fidelle, G. Kroemer et al. · 0 citations
Review Open access Sep 2026

Probiotics in Celiac Disease: Current Evidence and Future Directions

Celiac disease is often associated with gut microbiome alterations, which may play a role in autoimmunity to gluten peptides and upregulation of other autoinflammatory pathways. Probiotics of various formulations have been evaluated in attempts to normalize the gut microbiome and/or improve symptoms in Celiac disease,...

Christopher S. McLaughlin, S. Krishnareddy · 0 citations
Review Open access Oct 2026

Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics

The gut–skin axis links intestinal microbial activity with inflammatory skin disease, yet findings across atopic dermatitis, acne vulgaris, and psoriasis remain inconsistent. This review examines how disease biology and host context shape microbiome‐related effects and responses to probiotics.

Pranvi Sharma, Tanaka Nhokwara, Jaswinder Singh et al. · 0 citations
Open access Sep 2026

The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease

People with HIV (PWH) are at higher risk of cardiovascular disease (CVD) despite spontaneous or antiretroviral therapy‐induced long‐lasting suppressed viremia. Traditional and HIV‐specific factors have been identified, but CVD incidence and mortality remain high. A microbiome is a community of germs living close to the...

F. Ranzani, C. Montrucchio, I. Ferrocino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.